| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CALADRIUS BIOSCIENCES INC | 55,579 | 157,000 | 0.28% | ||
| 2 | BIOBLAST PHARMA LTD | 206,054 | 214,000 | 0.38% | ||
| 3 | OHR PHARMACEUTICAL INC | 204,137 | 306,000 | 0.54% | ||
| 4 | AXIS CAPITAL HOLDING | 112,500 | 446,000 | 0.78% | ||
| 5 | Aldeyra Therapeutics Inc | 135,800 | 727,000 | 1.28% | ||
| 6 | NEWLINK GENETICS CORP COM | 93,533 | 962,000 | 1.69% | ||
| 7 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 1,172,000 | 2.06% | ||
| 8 | SYNTHETIC BIOLOGICS INCORPORATED | 2,034,949 | 1,553,000 | 2.72% | ||
| 9 | ADVAXIS INC COM NEW | 225,000 | 1,611,000 | 2.83% | ||
| 10 | VOLITIONRX LTD | 461,538 | 2,091,000 | 3.67% | ||
| 11 | AMPIO PHARMACEUTICALS INC | 2,738,322 | 2,492,000 | 4.37% | ||
| 12 | ALCOBRA LTD | 1,205,498 | 2,532,000 | 4.44% | ||
| 13 | RITTER PHARMACEUTICALS INC | 952,434 | 2,581,000 | 4.53% | ||
| 14 | ANAVEX LIFE SCIENCES CORP | 724,205 | 2,868,000 | 5.03% | ||
| 15 | VASCULAR BIOGENICS LTD | 860,605 | 4,174,000 | 7.32% | ||
| 16 | ABEONA THERAPEUTICS INC | 2,359,767 | 11,445,000 | 20.08% | ||
| 17 | CORBUS PHARMACEUTICALS HLDGS | 2,563,925 | 21,665,000 | 38.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008952, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
